Therapeutic protein design is evolving—and it is doing so in more than one sense of that word. Protein design is being guided by artificial intelligence (AI), which drug developers are using to ...

Protein engineering will be critical to creating the next generation of therapeutics, chemicals, materials, and food. Artificial intelligence is poised to have a transformational impact on protein ...

In a remarkable leap forward for synthetic biology, the AI model ESM3, developed by Evolutionary Scale, has achieved a significant milestone. By simulating half a billion years of evolutionary ...

WHAT: The protein sequencing company, Quantum-Si, will discuss their novel next-generation protein sequencing platform, Platinum™, and how it can be used to identify proteins with single-molecule ...

Nature is pretty good at designing proteins. Scientists are even better. But artificial intelligence holds the promise of improving proteins many times over. Medical applications for such “designer ...

Antibody engineering enables the generation of novel and diverse antibody constructs. The development of therapeutic antibodies is highly dependent on antibody engineering, whether for the generation ...

Optimized chemistry enables direct synthesis of up to 500 bp double stranded fragments “Using our chemical synthesis platform we are able to directly synthesize Twist Multiplexed Gene Fragments as ...

AlphaFold was published in 2021 and seemingly overnight effectively solved the protein folding problem, which had been an open challenge for decades. Since then, AI and ML methods have transformed the ...

Many pharmaceutical companies are using computer modeling programs to help design classes of drugs to fit into protein active sites. Researchers at Duke University are doing the opposite to help ...